Weight optimization · Launchpad care path

Semaglutide — a compounded GLP-1 on the partner care path.

OpenLoop Launchpad includes compounded semaglutide in the macro GLP-1s bucket, alongside tirzepatide. After you see if you qualify, intake is hosted by OpenLoop: their clinicians review, and their licensed 503A pharmacy network fills a patient-specific prescription if appropriate. Compounded semaglutide is not an FDA-approved branded product and is not a generic equivalent of Wegovy or Ozempic. Care is not live until Launchpad is wired.

At a glance

What this page is built to clarify.

Care-path focus

On the Launchpad contract

Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo.

Care-path focus

Partner clinicians decide

Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo.

Care-path focus

Not a branded-drug substitute

Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo.

Clinical context

How to read this page.

These pages describe possible pathways, not a promise that any medication will be prescribed, shipped this week, or available in any state today. Livozo does not employ the prescriber.

Compounded semaglutide is not FDA-approved and is not a generic equivalent of Wegovy or Ozempic. Livozo does not prescribe. A partner clinician must review history and clinical need. This page is a care-path listing, not a promise that medication will be prescribed or shipped.
  • Weight-optimization goals a clinician may review
  • Metabolic context discussed with a partner clinician
  • Interest in semaglutide under medical review

Partner model

What the partner path can include.

When Launchpad is wired

  • Livozo marketing CTA, then OpenLoop white-label intake
  • Review by OpenLoop-affiliated licensed clinicians
  • Patient-specific 503A compounding through their pharmacy network when appropriate
  • Partner-hosted portal, shipping, and support — not a Livozo clinic

Potential options

  • Compounded semaglutide when a clinician documents need
  • Not interchangeable with FDA-approved branded GLP-1s
  • Tirzepatide is a separate Launchpad product page in the same contract bucket

Exact medication, formulation, quantity, refill timing, and pharmacy routing depend on the clinical partner, applicable law, and clinical appropriateness. OpenLoop's licensed 503A network — not an exclusive Red Rock claim — fulfills partner prescriptions if written.

Next step

See if you qualify — partner intake, not a live clinic.

This is a Launchpad care path, not live clinician care. A “see if I qualify” step is meant to hand off to OpenLoop white-label intake when that contract is wired. Until then, eligibility is informational. No prescription, charge, or shipment happens from this site.

See if I qualify

Also in this catalog

Related Launchpad pages.